Preserve access to safe and affordable prescription medicines for personal use while focusing enforcement on the highest-risk shipments.

“Americans should not lose access to affordable medicines simply because the government has better information about packages entering the country. We urge your agencies to use that information to focus enforcement on where the risks are greatest while preserving appropriate access to safe and affordable medicines for personal use,” the members concluded.

Budzinski signed a letter urging federal agencies to target enforcement toward higher-risk shipments while preserving access to safe, affordable medicines for personal use.

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · press_release · model gpt-5.5

unverified · Source version 90844 · locator unknown

“Nikki Budzinski (IL-13)” ... “focus enforcement on where the risks are greatest while preserving appropriate access to safe and affordable medicines for personal use”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Budzinski was listed among 71 House signers of a letter urging HHS, FDA, DHS, and CBP to preserve personal-use access while prioritizing high-risk shipments. This documents concrete effort, not delivery.

unresolved same_term A for effort

Pocan, Schakowsky Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports » Urban Milwaukee
secondary · model gpt-5.5 · confidence 86%

unverified · Source version 90846 · locator unknown

“establishes a new postal informal entry process” ... “Compliance date: The compliance date for 19 CFR 145.12(a)(2)(v) and (vi) is on October 22, 2026.”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The relevant CBP mail-entry rule remained scheduled for an October 22, 2026 compliance date after the lookback window, so the requested protection had not yet been delivered or definitively blocked as of October 13, 2026.

unresolved same_term

2026-12670.pdf
secondary · model gpt-5.5 · confidence 84%